Biodefense startup Valthos raises $30 million in funding, with participation from OpenAI
ChainCatcher news, biotechnology defense startup Valthos has raised $30 million in funding from the OpenAI Startup Fund, Lux Capital, and Founders Fund.
The company's AI system can update medical countermeasures according to the changing speed of biological threats, enabling researchers and government agencies to identify and respond to pathogens as quickly as possible. Valthos was founded in New York last November, and its leadership includes: former Palantir Technologies Head of Life Sciences Kathleen McMahon, former Oxford University computational neuroscience researcher Tess van Stekelenburg, and founding AI engineer Victor Mao (who previously served as a research engineer at Google DeepMind).
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Mgen Solutions announces shareholder meeting call
Sony (SONY.US) to miss the 2027 CES after dissolving joint venture with Honda (HMC.US), shifts focus to entertainment content
Sony Group (SONY.US) will not participate in the 2027 International Consumer Electronics Show (CES), ending its decades-long history of attending this major electronics event in Las Vegas. Instead, the company will shift its focus more towards its entertainment content business.
Intervention risk rises again! After signals from Japan and the US, Japan's top foreign exchange official warns: the market should take this seriously
Jun Azumi stated on Monday that the market should take seriously the "very clear" message about the yen issued last week by Tokyo and Washington. His remarks signal his readiness to take action to curb excessive depreciation of the yen.
Crypto prices
More
